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Background: While the elevated risk of suicide attempt among persons who inject drugs 
(PWID) is well documented, whether use of different substances is associated with varying 
degrees of risk remains unclear. We sought to examine the associations between substance use 
patterns and attempted suicide in a prospective cohort f PWID in Montreal, Canada.  
Methods: Between 2004 and 2011, participants completed an interviewer-administered 
questionnaire eliciting information on socio-demographic, substance use patterns, related 
behaviors, and mental health markers. Generalized estimating equations were used to model the 
relationship between self-reported use of six common substances (cocaine, amphetamine, 
opioids, sedative-hypnotics, cannabis and alcohol), associated patterns of use (chronic, 
occasional and none), and a recent (past six-month) suicide attempt. 
Results: At baseline, of 1,240 participants (median age: 39.1, 83.7% male), 71 (5.7%) reported a 
recent suicide attempt. Among 5,621 observations collected during follow-up, 221 attempts were 
reported by 143 (11.5%) participants. In multivariate nalyses adjusting for socio-demographic 
and psychosocial stressors, among primary drugs of abuse, chronic [Adjusted Odds Ratio 
(AOR): 1.97] and occasional (AOR: 1.92) cocaine use, and chronic amphetamine use (AOR: 
1.96) were independently associated with attempted suicide. Among co-used substances, chronic 
sedative-hypnotic use was independently associated wi h an attempt (AOR: 2.29). No 
statistically significant association was found for the remaining substances.   
Conclusion: Among PWID at high risk of attempted suicide, stimulant users appear to constitute 
a particularly vulnerable sub-group. While the mechanisms underlying these associations remain 
to be elucidated, findings suggest that stimulant-using PWID should constitute a prime focus of 
suicide prevention efforts. 
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Substance misuse constitutes a significant risk factor for suicide, second only to 
depression and other affective disorders (Cavanagh et al., 2003). Among illicit drug-users, 
suicide is a substantial contributor to excess mortality, estimated to account for more than 10% 
of deaths (Darke et al., 2007). Further, lifetime histories of suicide attempt in this population 
range between 17% and 43% (Darke et al., 2007). These proportions are far in excess to 
prevalences reported in the general population, estimated to vary between 3% and 5% (Health 
Canada, 2009; Kessler et al., 1999).  
Persons who inject drugs (PWID) seem to exhibit the greatest risk. Compared to the 
general population, intravenous drug use carries a nearly 14-fold elevated risk of completed 
suicide (Wilcox et al., 2004), and PWID are estimated to be four times more likely to experience 
an attempt compared to non-injection drug users (Darke nd Kaye, 2004). Studies conducted in 
the United States (Havens et al., 2004) and Canada (Marshall et al., 2011) among street-based 
PWID reported six-month prevalences of suicide attempt of 7.0% and 8.0%, respectively.  
While the relationship between substance misuse and risk of suicidal behavior is well 
established, it is unclear how this association varies across different types of substances among 
drug-using populations (Center for Substance Abuse Treatment, 2008). An extensive literature 
has focused on cocaine- (Darke and Kaye, 2004; Roy,2001) and heroin-users (Darke et al., 
2005; Roy, 2002, 2010) and reported comparable prevalences of attempted suicide, suggesting 
that both drugs may carry a similar risk of suicidal behaviors. Investigations conducted among 
broader drug-using populations noted a positive association between suicide attempt, and use of 
cocaine (Britton and Conner, 2010) and amphetamine (Marshall et al., 2011). Use of licit non-
injectable substances, including sedative-hypnotics and alcohol, which are often co-used by 
illicit drug users (Darke and Hall, 1995; Public Health Agency of Canada, 2006), has also been 
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reported to be associated with increased odds of attemp ed suicide (Backmund et al., 2011; 
Rossow and Lauritzen, 1999). In contrast, a number of studies failed to report an association 
between use of specific substances and suicide attempt (Havens et al., 2004; Roy, 2003; Wines et 
al., 2004). Although polysubstance use is highly prevalent among street-based PWID (Leri et al., 
2004), few investigations have examined a broad range of commonly used substances within the 
same study sample (Wines et al., 2004), making it diff cult to compare associations with 
attempted suicide across substances. Moreover, other findings are limited by a lack of control for 
important confounding factors implicated in suicidal behaviors, such as mental health status 
(Marshall et al., 2011).  
Given that one of the most powerful predictors of death by suicide is a previous suicide 
attempt (Christiansen and Jensen, 2007), it is important to identify drug users who are most 
likely to engage in suicidal behaviors. Having a better understanding of the possible risks carried 
by use of specific substances in this population provides a way to guide and prioritize suicide 
prevention efforts (Center for Substance Abuse Treatm nt, 2008). In this study, we sought to 
examine the relationship between patterns of substance use and attempted suicide using data 
collected as part of a prospective cohort study of polysubstance-using PWID recruited in 
Montreal, Canada.  
2.0 Methods  
2.1 Participants 
The study sample was selected from the HEPatitis COhort (HEPCO), an ongoing 
prospective investigation of PWID established in Montreal, in 2004, to study determinants of 
Hepatitis C Virus (HCV) transmission. Cohort recruitment and follow-up procedures have been 
described in detail previously (Bruneau et al., 2012). Briefly, eligibility criteria included having 
injected drugs within the previous six months, being 18 years of age or older, residing in the 
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Greater Montreal area and providing informed consent in compliance with institutional review 
board regulations of the Centre Hospitalier de l’Université de Montréal (CHUM). Participant 
recruitment occurred through street-level strategies such as word-of-mouth and community 
program referrals.  
At baseline and each six-month follow-up visit, participants provided blood samples for 
HCV testing and completed an interviewer-administered questionnaire eliciting information on 
socio-demographic characteristics, detailed information on substance use patterns and related 
behaviors in the past month and past six months, and mental health status indicators. The 
interviewers and nurses present on-site offered information about, and referrals to addiction, 
mental health and HCV treatment or support services on a case-by-case basis. A CAD 15.00$ 
stipend was offered to all study participants upon c mpletion of the questionnaire, as 
compensation for their time. Ethical approval for this study was provided through the Ethics 
Review Board of the CHUM. 
Between November, 2004 and March, 2011, a total of 1,243 PWID were recruited in the 
HEPCO cohort, and were eligible for this study. Three participants were excluded from the 
present analyses, as they had missing data for the outcome of interest.   
2.2 Measures 
Consistent with previous reports (Marshall et al., 2011), the outcome of interest was a 
dichotomous measure of suicide attempt assessed by the following question: “In the past six 
months, have you attempted suicide?”.  
The primary exposure variables were substance use patt rns. Participants were 
questioned on the types of substances used in the previous six months, and on the corresponding 
number of days of use. A conceptual domain assessing ubstance use patterns was created, and 
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included the types of substances used and associated p t rns of use. Six types of commonly used 
substances were assessed: cocaine, amphetamine, opioids, including heroin and prescription 
opioids, cannabis, alcohol and sedative-hypnotics, in luding barbiturates and benzodiazepines. 
Given that eligible participants must have injected drugs in the previous six months, cocaine, 
amphetamine and opioids constitute the primary drugs of abuse in our sample, whereas the 
remaining substances are typically co-used. Patterns of substance use were operationalized in 
three groups: chronic, occasional or none, based on the umber of days of use in the previous six 
months. In the absence of formal guidelines distinguishing between chronic and occasional 
substance use, we relied on the definition used by the United States Office of National Drug 
Control Policy to describe patterns of illegal drug use (Office of National Drug Control Policy, 
2012). Accordingly, chronic drug use is defined as consumption that occurs once a week or 
more, and occasional use as consumption that takes place less frequently. A similar definition 
has been successfully employed in a previous study assessing patterns of drug use in relation to 
suicidal behaviors among drug users (Wines et al., 2004). In line with this definition, in our 
study, chronic substance use, with the exception of alc hol, was defined as having consumed on 
26 days or more in the previous six months, and occasional use as having consumed up to 25 
days over the same time period. As alcohol is more wid ly consumed compared to all of the 
other drugs, we opted for a less conservative definition to describe chronic use. As such, chronic 
use of alcohol was defined as having consumed, on average, every other day or more in the past 
six months (i.e., ≥90 days), and occasional use as having consumed less frequently. A third 
category (none), indicating no consumption in the previous six months, was also included for all 
substance use variables. 
Potential confounders included measured variables pr viously identified as significant 
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correlates of suicide attempt among drug-using populations (Havens et al., 2004; Marshall et al., 
2011), and were grouped into two conceptual domains: socio-demographic characteristics and 
psychosocial stressors. Age, gender and education were assessed as part of the socio-
demographic domain. Variables examined in the psychosocial stressors domain included living 
in unstable housing conditions, prostitution, incarceration, characteristics of injection drug use 
relevant to the study population, including the frequ ncy of injection (>30 versus ≤30 injections, 
past month), age at first injection and duration of injection drug use, and markers of 
psychological distress. Two variables were assessed a  markers of psychological distress, and 
included history of a diagnosed psychological disorder and treatment for anxiety or depression. 
Detailed information regarding the type of psychological disorder was not collected. Consistent 
with previous studies (Bruneau et al., 2012), unstable housing was defined as living on the street, 
in shelters or in apartment-hotels rented on a monthly basis, indicating rapid turnover compared 
to typical 12-month rent–lease accommodation standards in Montreal. All factors in the 
psychosocial stressors domain were assessed in reference to the past six months, with the 
exception of diagnosed psychological disorder, which was in reference to lifetime.  
2.3 Statistical analyses 
Descriptive statistics were used to characterize the s udy sample at baseline, and included 
medians and corresponding interquartile ranges (IQR), and frequency distributions for 
continuous and categorical variables, respectively. To compare the characteristics of participants 
who did and did not experience a suicide attempt at baseline, chi-square tests were conducted for 
categorical variables and nonparametric Mann-Whitney U-tests for continuous variables, given 
their non-normal distribution.  
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To examine factors associated with reports of suicide attempt throughout the entire 77–
month period, while accounting for within-subject correlation as a result of repeated 
measurements, we used generalized estimating equations (GEE) analyses for binary outcomes 
with autoregressive order 1 covariance structure (Zeger et al., 1988). In a first step, bivariate 
GEE analyses were conducted for substance use patterns and potential confounders, and suicide 
attempt to calculate crude odds ratios (OR) and corresponding 95% Confidence Intervals (CI). 
Subsequently, a multivariate GEE model was constructed to identify substance use patterns that 
were independently associated with attempted suicide. Model building was carried out by 
introducing, in a sequential manner, blocks of variables pertaining to each of the three pre-
defined domains. Specifically, substance use patterns were entered first, followed by the socio-
demographic and the psychosocial stressor domains. Thi  sequential introduction of variables 
permitted the assessment of socio-demographic charateristics and psychosocial stressors as 
potential confounders of the associations between substance use patterns and suicide attempt. To 
ensure that only the most informative variables were r tained, those that were statistically 
significant at the p-value<0.10 level within each domain were selected through a process of 
backward elimination, and subsequently introduced in the final, multivariate model. For all 
analyses, p-values were two-sided. Statistical analyses were pformed using SAS 9.3 software 
(SAS Institute).  
3.0 Results 
3.1 Sample characteristics 
Table 1 presents baseline characteristics among the 1,240 participants eligible for the 
analyses. Median age was 39.1(IQR: 30.2 – 45.6), the majority (83.7%) was male and less than 
two-thirds (60.2%) completed high-school education. Regarding substance use patterns, among 
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primary drugs of abuse, cocaine was the most commonly used drug (56.7% chronic and 30.1% 
occasional), followed by opioids (36.2% chronic and 21.1% occasional) and amphetamine (2.5% 
chronic and 13.3% occasional). Among co-used substances, more than two-thirds of participants 
indicated using alcohol (8.1% chronic and 71.0% occasional) and cannabis (49.6% chronic and 
22.8% occasional), and nearly half reported using sedative-hypnotics (23.3% chronic and 18.4% 
occasional). Overall, participants presented characte istics often associated with drug addiction 
severity and chronicity. Approximately one in two PWID reported living in unstable housing 
conditions (42.4%) and a high-injection frequency (50.5%). The median time of injection 
duration was 12.6 years (IQR: 6.7 – 21.3). Further, a significant proportion of participants had a 
history of a diagnosed psychological disorder (28.2%) and received recent treatment for anxiety 
or depression (26.4%).   
At baseline, seventy-one PWID (5.7%) reported a suicide attempt in the preceding six 
months. Table 1 compares baseline characteristics between attempters and non-attempters. 
Attempters were more likely to be female (26.8% versus 15.7%). Regarding substance use 
patterns, they were also more likely to report chronic (7.2% versus 2.3%) and occasional (17.4% 
versus 13.1%) use of amphetamine, and chronic use of s dative-hypnotics (44.3% versus 
22.0%). No statistically significant differences were found for the remaining substances. 
Participants who attempted suicide were also more likely to report characteristics of greater 
psychological distress. For instance, compared to non-attempters, a significantly higher 
proportion of attempters reported a history of a diagnosed psychological disorder (52.9% versus 
26.7%).  
3.2 Associations of substance use patterns with suicide attempt  
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 Overall, participants contributed to 5,621 observations during the 77-month follow-up. 
Eight hundred and seventy-nine (70.9%) had at leastone follow-up visit, and the median number 
of visits was 4 (IQR: 2–8). A total of 221 suicide attempts were reported during follow-up by 
143 (11.5%) participants. Among participants who experienced a suicide attempt, the median 
number of attempts during follow-up was 1 (IQR: 1 –2). 
 Table 2 presents crude associations between socio-dem graphic characteristics, substance 
use patterns and psychosocial stressors, and suicide attempt from bivariate GEE analyses. 
Among socio-demographic characteristics, older age and male were statistically significantly 
associated with lower odds of attempting suicide. Overall, substance use patterns pertaining to all 
three primary drugs of abuse were significantly associated with increased odds of reporting an 
attempt, whereas among co-used substances, only chroni  and occasional use of sedative-
hypnotics was significantly associated with the outc me. In addition, several markers of 
psychosocial stress were associated with increased odds of reporting an attempt, including recent 
treatment for anxiety or depression, and having a history of a diagnosed psychological disorder.  
Results from the multivariate GEE analyses illustrating the associations between 
substance use patterns and suicide attempt, adjusting, equentially, for socio-demographic 
characteristics and markers of psychosocial stress, are presented in Table 3. Model A presents 
the odds ratios for having experienced a suicide attempt according to all substance use patterns 
that met the inclusion criterion for retention in the multivariate model, and included chronic 
[Adjusted Odds Ratios (AOR): 2.09, 95% CI: 1.22 – 3.58)] and occasional (AOR: 1.79, 95% CI: 
1.06 – 3.04) use of cocaine, chronic (AOR: 2.35, 95% CI: 1.18 – 4.70) and occasional (AOR: 
1.61, 95% CI: 1.10 – 2.35) use of amphetamine, and chronic (AOR: 2.75, 95% CI: 1.96 – 3.86) 
and occasional (AOR: 1.65, 95% CI: 1.08 – 2.50) use of sedative-hypnotics. The addition of 
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socio-demographic factors in Model B resulted in small changes (10-13%) in the estimates of 
cocaine and amphetamine use patterns, whereas negligible changes were noted in the estimates 
of sedative-hypnotics. Further adjustment for psychosocial stressors in Model C led to a 
reduction in the AOR of all substance use patterns of up to 15%. For the most part, substance use 
patterns remained independently associated with suicide attempt in the final model. Specifically, 
the odds of reporting a suicide attempt were greate for chronic (AOR: 1.97, 95% CI: 1.14 – 
3.41) and occasional (AOR: 1.92, 95% CI: 1.12 – 3.30) use of cocaine, chronic (AOR: 1.96, 95% 
CI: 1.01 – 3.80) and occasional (AOR: 1.41, 95% CI: 0.95 – 2.09) use of amphetamine, and 
chronic (AOR: 2.29, 95% CI: 1.61 – 3.26) and occasional (AOR: 1.48, 95% CI: 0.95 – 2.29) use 
of sedative-hypnotics.  
 4.0 Discussion 
Consistent with previous reports (Havens et al., 2004; Marshall et al., 2011), our findings 
indicate that suicide attempt is a frequent event among PWID in Montreal. At baseline, nearly 
6% of participants reported an attempt within the previous six months. The present study sought 
to examine the associations between patterns of substance use and attempted suicide in this high-
risk population.  
4.1 Main findings 
Findings indicate that among primary drugs of abuse,  of stimulants is, by and large, 
associated with elevated odds of reporting a suicide attempt, whereas use of opioids is not, after 
controlling for use of other drugs and important confounders, including history of a 
psychological disorder. We noted that chronic and occasional use of cocaine and chronic use of 
amphetamine was associated with nearly two-fold greate  odds of reporting an attempt. 
Similarly, among substances that are typically co-used by illicit drug-using populations, chronic 
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use of sedative-hypnotics was associated with two-fold elevated odds of attempted suicide. This 
study uniquely adds to the literature by examining a broad range of commonly used substance 
types and associated patterns of use within a largesample of polydrug-using PWID, while 
controlling for several factors previously linked to suicidal behaviors.  
4.2 Associations of stimulant use patterns with suicide attempt  
Our findings illustrating a positive association betw en suicide attempt and use of 
cocaine and amphetamine are in agreement with a number of previous studies. In a multi-city 
study conducted in the United States among a clinical sample of drug users, participants 
reporting cocaine use as their primary drug of choie had three-fold greater odds of attempting 
suicide at one-year follow-up (Britton and Conner, 2010). Among street-based PWID in 
Vancouver, methamphetamine injection was found to increase the risk of attempted suicide by 
80% (Marshall et al., 2011). Though previous research has reported elevated prevalences of 
suicidal behaviors among opioid-dependent individuals compared to the general population 
(Darke and Ross, 2002), to our knowledge, no study has reported an independent association 
between opioid use and suicidality among drug-using populations. Altogether, these findings 
suggest that, while substance use, in and out itself, carries a significant risk for suicidal 
behaviors, stimulant users may be a particularly vunerable population, and should constitute a 
focal target group of suicide prevention efforts among the broader PWID community.  
A range of neurobiological, behavioral and social dfferences between stimulant and 
opioid users could account for these findings. First, the anhedonic state often associated with use 
of stimulants may play a role in heightening vulnerability to suicidal behaviors. Supporting this 
presumption, several imaging studies reported dopamine hypoactivity among long-term cocaine 
and amphetamine users (Volkow et al., 2001; Volkow et al., 1997), which has been implicated in 
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inducing a chronic state of anhedonia and heightened vulnerability to suicide (Dackis and 
O'Brien, 2001). A second possible explanation for our finding relates to the varying degrees of 
impulsivity seen across users of stimulants and opioids. There is evidence to suggest that, 
compared to opiate users, cocaine and amphetamine users have poorer levels of impulse control 
(Badiani et al., 2011), and impulsive behaviors have been implicated in a substantial proportion 
of attempted suicides (Simon et al., 2001). It is unclear, however, whether differences in 
impulsivity are due to the drug itself or pre-existing differences, though preliminary evidence 
points toward the former possibility (Badiani et al., 2011).  
Finally, the more limited opportunities for engagement in care made available to 
stimulant users, compared to opiate users, are also likely to account for our findings. 
Traditionally, addiction treatment services have ben structured around opiate users, and have 
been slower to adapt to patterns of stimulant misuse (Foers et al., 2004). Among heroin users, 
opiate substitution therapy has been linked to greate  linkage with health care services (Spire et 
al., 2007), and a plethora of positive health and social outcomes, including reductions in drug use 
(Sees et al., 2000), susceptibility to infection with Human Immunodeficiency Virus (MacArthur 
et al., 2012), non-fatal overdose (Kerr et al., 2007) and involvement in crime (Keen et al., 2000). 
By establishing timely contacts with health care servic s and helping improve the overall health 
of drug users, opiate substitution therapy may have a positive impact on their vulnerability to 
suicidal behaviors. In support of this hypothesis, a tudy conducted in New South Wales, 
Australia noted significant reductions in depression and suicidal thoughts, plans and attempts in a 
sample of 387 heroin-users, three years following etry in drug addiction treatment (Darke et al., 
2009). For stimulant users, pharmacological therapis are still under development (Ciccarone, 
2011), and the effectiveness of psychosocial interventions is compromised by poor treatment 
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initiation and retention rates (Shearer, 2007). Compared to heroin users, stimulant users are 
substantially less likely to initiate drug treatment (John et al., 2001) and are more prone to 
relapse following cessation of drug use (Nosyk et al., 2014), suggesting that health care services 
may fail to reach and engage stimulant users into care as effectively as opiate users. Innovative 
care models involving assertive outreach, adapted to the unique profile of stimulant users, may 
prove useful in reaching this difficult-to-engage sub-group of PWID. Research conducted in 
Rotterdam, Netherlands illustrated that such models can have positive impacts on treatment 
engagement, and physical and mental health among chroni  high-risk crack cocaine users who 
were previously inadequately engaged in care (Henskens et al., 2008).  
4.3 Associations of sedative-hypnotic use patterns with suicide attempt  
In our study, chronic use of sedative-hypnotics wasassociated with approximately two-
fold greater odds of reporting a suicide attempt, finding that is consistent with a previous study 
conducted among PWID (Backmund et al., 2011). Given that nearly half of participating PWID 
reported using sedative-hypnotics, regular screening regarding the use of such drugs in this 
population is deemed necessary.  
A number of explanations could account for this finding. First, the elevated odds of 
suicide attempt among PWID using sedative-hypnotics could reflect an attempt to self-
medication as a result of an underlying psychiatric comorbidity (Rigg and Ibanez, 2010). In our 
study, chronic use of sedative-hypnotics remained associated with suicide attempt even after 
controlling for the presence of a diagnosed psychological condition. Though, it is possible that 
our definition missed conditions that have never been clinically diagnosed. Second, finding could 
also be attributed to the disinhibiting properties of certain sedatives. Increased impulsivity and 
aggressive behavior following use of these drugs has been reported in some individuals (5-10%), 
 17 
which may lead to a reduced threshold for taking action on suicidal thoughts. Finally, the 
observed positive association with attempted suicide may also reflect easy access to a common 
means for attempting suicide (Darke and Ross, 2002).  
4.4 Associations of psychosocial stressors with suicide attempt  
Among psychosocial stressors, high-injection frequency and history of a diagnosed 
psychological disorder were found to be positively associated with suicide attempt. The 
association with high injection frequency may be reflective of a sub-group of PWID who has a 
more drug-affected lifestyle and therefore, is more vulnerable to experiencing multiple risk 
factors for suicidal behaviors (Harris et al., 2013). The role of psychological distress in elevating 
the risk of suicidal behaviors is well-established (Cavanagh et al., 2003). Given the 
preponderance of psychological disorders among drug-using populations, mental health 
assessment should constitute an integral part of addiction treatment and community-based 
support services.  
4.5 Limitations 
Our findings must be considered in light of several limitations. Given the observational 
nature of our study and the absence of information regarding the sequence of events, causal 
inferences regarding the associations between substance use patterns and suicide attempt cannot 
be made. While the socio-demographic and drug use chara teristics of participants are, by and 
large, reflective of the PWID population in Quebec (Public Health Agency of Canada, 2006), the 
HEPCO cohort is not a random sample, thereby limiting he generalisability of our findings. 
Moreover, as data for this study were collected through self-report, social desirability bias might 
arise as a result of eliciting information on socially sensitive behavior, though self-reported data 
collected from drug-using populations appear to be generally reliable and valid (Darke, 1998). 
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Furthermore, though we controlled for markers of psychological distress, results should be 
interpreted with caution given the absence of validate  instruments assessing mental health. The 
lack of detailed characteristics of suicide attempts (e.g. severity of attempt) also limited our 
ability to identify specific factors relevant to different types of suicidal behaviors. Finally, other 
factors previously linked to suicidal behaviors, including childhood abuse and a family history of 
suicide (Hawton and van Heeringen, 2009), were not measured in our study, and therefore, 
residual confounding may explain the observed associati ns with attempted suicide.  
4.6 Conclusion  
Altogether, our study points toward a unique link between stimulant use and suicide 
attempt that does not seem to pertain to use of opiids, thereby providing preliminary evidence 
that distinct substance use patterns may play a role in shaping PWID’s vulnerability to suicidal 
behaviors. Although further research is needed to delineate the possible direction of causality 
between substance use and suicide attempt, findings suggest that stimulant-using PWID should 
constitute a prime focus of suicide prevention efforts among the broader injecting community. 
Future studies coupling behavioral and basic sciences may be fruitful in better understanding the 
neurobiological, behavioral and social factors thatpossibly work to increase the risk of suicide 
attempt in this group. Finally, as simultaneous use of multiple substances is a common behavior 
among drug-using populations, future research should f cus on examining the role of substances 
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Table 1: Descriptive characteristics of the study sample at baseline, stratified by whether or not 





















Socio-demographic factors    
Age     
Median 
   (IQR) 
39.1 




(30.3 – 45.6) 
0.110 
Gender     
Male 1038 (83.7) 52 (73.2) 983 (84.3) 0.014 
Female 202 (16.3) 19 (26.8) 183 (15.7)  
Completed high-school education   
Yes 746 (60.2) 42 (59.2) 704 (60.2) 0.858 
No  494 (39.8) 29 (40.8) 465 (39.8)  
Substance use patterns past six months b   
Cocaine     
Chronic 693 (56.7) 44 (62.9) 649 (56.2) 0.408 
Occasional 369 (30.1) 20 (28.6) 349 (30.2)  
None 162 (13.2) 6 (8.6) 156 (13.5)  
Amphetamine     
Chronic 31 (2.5) 5 (7.2) 26 (2.3) 0.019 
Occasional 163 (13.3) 12 (17.4) 151 (13.1)  
None 1029 (84.1) 52 (75.4) 977 (84.7)  
Opioids     
Chronic 436 (36.2) 31 (44.9) 405 (35.7) 0.059 
Occasional 254 (21.1) 18 (26.1) 236 (20.8)  
None 515 (42.7) 20 (29.0) 495 (43.6)  
Sedative-hypnotics    
Chronic 284 (23.3) 31 (44.3) 253 (22.0) <0.001 
Occasional 225 (18.4) 10 (14.3) 215 (18.7)  
None 711 (58.3) 29 (41.4) 682 (59.3)  
Cannabis     
Chronic 605 (49.6) 34 (49.3) 571 (49.6) 0.914 
Occasional 278 (22.8) 17 (24.6) 261 (22.7)  
None 338 (27.7) 18 (26.1) 320 (27.8)  
Alcohol     
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Chronic 99 (8.1) 6 (8.5) 93 (8.1) 0.966 
Occasional 870 (71.0) 51 (71.8) 819 (71.0)  
None 256 (20.9) 14 (19.7) 242 (21.0)  
Psychosocial stressors     
Living in unstable housing conditions past six months  
Yes 525 (42.4) 25 (35.2) 500 (42.8) 0.209 
No  714 (57.6) 46 (64.8) 668 (57.2)  
Prostitution past six months    
Yes 142 (11.5) 17 (23.9) 125 (10.7) <0.001 
No  1098 (88.5) 54 (76.1) 1044 (89.3)  
Incarceration past six months    
Yes 272 (22.0) 11 (15.5) 261 (22.4) 0.174 
No 965 (78.0) 60 (84.5) 905 (77.6)  
Treatment for anxiety or depression past 6 months  
Yes 327 (26.4) 32 (45.1) 295 (25.2) <0.001 
No 913 (73.6) 39 (54.9) 874 (74.8)  
History of a psychological disorder   
Yes 348 (28.2) 37 (52.9) 311 (26.7) <0.001 
No 888 (71.8) 33 (47.1) 855 (73.3)  
Number of injections past month   
>30 626 (50.5) 41 (57.8) 585 (50.0) 0.208 
≤30 614 (49.5) 30 (42.3) 584 (50.0)  
Age at first injection    
Median 
   (IQR) 
21.0  
(17.0 – 28.0) 
20 
(17.0 - 28.0) 
20 
(17.0 – 29.0) 
0.427 
Duration of injection (years)    
Median 
   (IQR) 
12.6 
(6.7 – 21.3) 
11.1 
(7.9 - 20.1) 
12.7 
(6.7 – 21.3) 
0.669 
 
Abbreviation: IQR, interquartile range 
a p-value derived from the χ2 test for categorical variables and the Mann-Whitney U-test for 
continuous variables  
b Chronic and occasional use of cocaine, amphetamine, opioids, sedative-hypnotic drugs and 
cannabis: ≥26 and <26 days in the previous six months, respectively; Chronic and occasional use 
of alcohol: ≥90 and <90 days in the previous six months, respectively 
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Table 2: Associations between socio-demographic factors, substance use patterns and 
psychosocial stressors, and suicide attempt, by univariate generalized estimating equation 
analyses (N=5,621 observations) 
Variable Unadjusted Odds Ratio 
(95% Confidence Intervals) 
Socio-demographic factors  
Age (per 5 year older) 0.90 (0.82 - 0.99)* 
Male gender 0.47 (0.30 - 0.74)* 
Completed high-school education 0.78 (0.55 - 1.10) 
Substance use patterns past six months a  
Cocaine  
Chronic 2.13 (1.28 – 3.55)**  
Occasional  1.85 (1.11 – 3.09)* 
Amphetamine  
Chronic 2.73 (1.47 – 5.05)**  
Occasional 1.88 (1.31 - 2.71)**  
Opioids  
Chronic 1.74 (1.23 – 2.47)**  
Occasional 1.64 (1.12 – 2.39)* 
Sedative-hypnotics  
Chronic 2.89 (2.08 – 4.01)**  
Occasional 1.87 (1.24 – 2.82)**  
Cannabis  
Chronic 1.17 (0.80 – 1.70) 
Occasional 1.25 (0.85 – 1.84) 
Alcohol  
Chronic 1.35 (0.78 – 2.34) 
Occasional 1.21 (0.87 – 1.67) 
Psychosocial stressors  
Living in unstable housing conditions past six months 1.31 (0.97 - 1.78) 
Prostitution past six months 2.06 (1.26 - 3.38)**  
Incarceration past six months 1.32 (0.98 - 1.76) 
Treatment for anxiety or depression past six months 2.56 (1.84 - 3.56)**  
History of a psychological disorder 3.25 (2.39 - 4.41)**  
>30 injections past month 1.48 (1.14 - 1.93)**  
Age at first injection (per year older) 0.98 (0.96 - 1.01) 
Duration of injection  (per year older) 0.99 (0.97 - 1.01) 
a The reference category is “none” 
*p-value< 0.05; ** p-value< 0.01 
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Table 3: Associations between substance use patterns and suici e attempt, with incremental 
introduction of variables pertaining to the socio-demographic and psychosocial stressors 







AOR (95% CI) 
Model B  
+Socio-demographic 
characteristics 
AOR (95% CI) 
Model C  
+Psychosocial 
stressors 
AOR (95% CI) 
Substance use patterns past six months a     
Cocaine    
   Chronic 2.09** (1.22 – 3.58) 2.31** (1.19 – 3.40) 1.97* (1.14 – 3.41) 
Occasional 1.79*   (1.06 – 3.04) 2.01** (1.37 – 3.91) 1.92* (1.12 – 3.30) 
Amphetamine    
Chronic 2.35* (1.18 – 4.70) 2.04* (1.02 – 4.07) 1.96* (1.01 – 3.80) 
Occasional 1.61* (1.10 – 2.35) 1.42 (0.97 – 2. 08) 1.41 (0.95 – 2.09) 
Sedative-hypnotics    
Chronic 2.75** (1.96 – 3.86) 2.76** (1.94 – 3.92) 2.29** (1.61 – 3.26)  
Occasional 1.65* (1.08 – 2.50) 1.61* (1.06 – 2.45) 1.48 (0.95 – 2.29) 
Socio-demographic characteristics   
Age  0.91 (0.82 - 1.01) 0.91 (0.82 - 1.01) 
Male gender  0.56* (0.34 - 0.93) 0.65 (0.40 - 1.07) 
Psychosocial stressors    
Unstable housing conditions 
past six months 
  1.26 (0.90 - 1.76) 
Prostitution past six months   1.20 (0.71 - 2.03) 
History of a psychological 
disorder  
  2.84** (2.05 - 3.95) 
>30 injections past month     1.35* (1.01 - 1.81) 
 
a The reference category is “none” 
Abbreviations: AOR, adjusted odds ratios; CI, confidence interval 
*p-value< 0.05; ** p-value< 0.01 
 
 
 
